| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/11/2004 | CN1161336C Quinolinecarboxamides as antiviral agents |
| 08/11/2004 | CN1161142C Medicinal composition for improving memory |
| 08/11/2004 | CN1161125C Blood-type grasserie preventing and treating medicine for silkworm and its prepn |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 08/11/2004 | CN1161116C Use of L-Carnitine and derviatives for reducing ceramide levels and potentiating antiretroviral |
| 08/11/2004 | CN1161107C Oral formulation for gastrointestinal drug delivery |
| 08/11/2004 | CN1161105C Flowable grug precursor product for compressing tablet, pill and coated tablet, and preparing method thereof |
| 08/10/2004 | US6774259 Condensation of alanine with alkyl butyrate; hydrogenation using palladium-on-carbon catalyst in water and sodium hydroxide; precipitation, filtration; recrystallization from acetonitrile; purification |
| 08/10/2004 | US6774241 Ht3 receptor antagonists for nervous system, psychological, eating, and sleep disorder treatment |
| 08/10/2004 | US6774237 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents |
| 08/10/2004 | US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif) |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders |
| 08/10/2004 | US6774212 For therapy of viral infection or as an assay standard or reagent |
| 08/10/2004 | US6774135 1-deoxy-galactonojirimycin and related compounds used to treat fabry disease |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774129 Alpha 2-adrenoceptor antagonists; antidepressants and treating parkinson's disease |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
| 08/10/2004 | US6774104 Cyclic polypeptide stabilized with lactose |
| 08/10/2004 | US6773881 By modulating vascular endothelial growth factor (vegf) |
| 08/10/2004 | US6773729 Administering combination of ginseng and ginkgo to improve the speed of memory and memory quality in normal, healthy subjects and to prevent deterioration of the speed of memory in people with decreased cognitive functions |
| 08/10/2004 | US6773728 Herbal composition of blend of active components prepared from murrya koenigii and piper betle useful for blocking of 5 lipoxygenase activity leading to the inhibition of leukotriene synthesis, suppression of interleukin-4 production, and enhancement of gamma interferon release |
| 08/10/2004 | US6773725 Kaoline, potassium sulfate, sodium sulfate, feldspar, talc and ferric oxide; activating physiological activity |
| 08/10/2004 | US6773723 Collagen/polysaccharide bilayer matrix |
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | CA2245169C Process for the preparation of 2,5-disubstituted pyridines |
| 08/10/2004 | CA2234899C Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist, method for preparation and use thereof in the treatment of cardiovascularillnesses |
| 08/10/2004 | CA2136238C Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
| 08/05/2004 | WO2004065626A2 A method of sepsis prognosis |
| 08/05/2004 | WO2004065607A1 Novel physiologically active substance rs-k3574 and process for producing the same |
| 08/05/2004 | WO2004065419A1 Antibody and use thereof |
| 08/05/2004 | WO2004065389A1 Pyrrolopyrimidine derivatives useful as modulators of multidrug resistance |
| 08/05/2004 | WO2004065385A1 Novel nitrogen-containing cyclic compounds |
| 08/05/2004 | WO2004065365A1 8-azaprostaglandin derivatives and medicinal uses thereof |
| 08/05/2004 | WO2004065353A1 Compounds for the inhibition of rotamases |
| 08/05/2004 | WO2004064865A1 Skeletal muscle protecting agent |
| 08/05/2004 | WO2004064858A1 Drug containing human arterial natriuretic peptide |
| 08/05/2004 | WO2004064857A1 Drugs containing galectin 9 |
| 08/05/2004 | WO2004064849A1 Means for normalising structure and functions of organs and tissues, stimulating injury recovery and exhibiting antiviral activity |
| 08/05/2004 | WO2004064825A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 08/05/2004 | WO2004064823A1 Ceramide derivatives for the treatment of inflammation |
| 08/05/2004 | WO2004064819A1 Sphingolipids for improvement of the composition of the intestinal flora |
| 08/05/2004 | WO2004064764A2 Substituted alkyl amido piperidines |
| 08/05/2004 | WO2004054983A3 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 08/05/2004 | WO2004041809A3 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003070204A3 Lipase inhibiting composition |
| 08/05/2004 | WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | US20040153126 Method and apparatus for treating uterine myoma |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152892 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152888 novel benzodiazepine derivatives |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152771 Mixture with biguanidine drug; antidiabetic agents; insulin resistance |
| 08/05/2004 | US20040152768 NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152757 Carvedilol |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152744 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; antichoilesterol agents; cardiovascular disorders |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152735 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152709 New compound for the treatment of impotence |
| 08/05/2004 | US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152684 Administering at least one 17 alpha -fluoralkylated progesterone receptor antagonist to the female subject during the post-ovulatory phase of the endometrial cycle inhibiting the occurrence of advanced endometrium maturation |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152672 Indole compounds useful for the treatment of cancer |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof |
| 08/05/2004 | US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |